Aubrey Remmers, MD

Principal investigator · Missoula, Montana

← All Investigators

Aubrey Remmers, MD

Principal investigator

Clinical background and research leadership

Family medicine & obesity medicine

Dr. Remmers combines more than two decades of family-medicine experience with American Board of Obesity Medicine certification earned in 2026. She joined Boeson as a sub-investigator in 2022 and has served as a principal investigator since 2023.

Clinical and research leadership: Her background includes service as Family Medicine Department Chair and Executive Committee Board Member at Western Montana Clinic, quality-committee work and residency teaching. Her clinical experience spans adult primary care, geriatrics and women’s health.

Boeson research experience: Her PI portfolio spans obesity, type 1 and type 2 diabetes, cardiovascular risk, influenza and other vaccines. Her metabolic research includes oral and injectable incretin-based therapies and studies addressing weight management, glycemic control and cardiovascular outcomes. Across PI and Sub-I roles, her vaccine and infectious-disease experience includes influenza, COVID-19, CMV and RSV, with RSV research involving older adults and pediatric populations. Additional Sub-I work includes atopic dermatitis and urinary tract infection research.

Training: MD, University of South Dakota School of Medicine; family-medicine residency, Quad Cities Genesis Family Practice; BA in Psychology, Creighton University.

Study fit: Select Dr. Remmers for the combination of obesity-medicine expertise, broad primary-care experience and an established metabolic and vaccine research portfolio.

Related research areas

Bring your next study to Boeson

Put this expertise to work on your next protocol. Share your study synopsis, target population and timeline to begin investigator and site selection with Boeson.

Request an investigator CV and relevant study experience to support your site-selection review.

Explore the local investigator team

Discuss a study with Boeson

Send your nonconfidential synopsis to start site selection with our team.

Investigator profile updated September 2026. Looking to participate? Explore study opportunities.